Literature DB >> 22733393

Radioiodine treatment of well-differentiated thyroid cancer.

Leonard Wartofsky1, Douglas Van Nostrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22733393     DOI： 10.1007/s12020-012-9729-5

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  40 in total

1.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  In vivo quantitation of lesion radioactivity using external counting methods.

Authors:  S R Thomas; H R Maxon; J G Kereiakes
Journal:  Med Phys       Date:  1976 Jul-Aug       Impact factor: 4.071

3.  Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

Authors:  R Michael Tuttle; Rebecca Leboeuf; Richard J Robbins; Rebecca Qualey; Keith Pentlow; Steven M Larson; Chee Y Chan
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

4.  Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

Authors:  P W Ladenson; L E Braverman; E L Mazzaferri; F Brucker-Davis; D S Cooper; J R Garber; F E Wondisford; T F Davies; L J DeGroot; G H Daniels; D S Ross; B D Weintraub
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

5.  Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

Authors:  Ujjal Mallick; Clive Harmer; Beng Yap; Jonathan Wadsley; Susan Clarke; Laura Moss; Alice Nicol; Penelope M Clark; Kate Farnell; Ralph McCready; James Smellie; Jayne A Franklyn; Rhys John; Christopher M Nutting; Kate Newbold; Catherine Lemon; Georgina Gerrard; Abdel Abdel-Hamid; John Hardman; Elena Macias; Tom Roques; Stephen Whitaker; Rengarajan Vijayan; Pablo Alvarez; Sandy Beare; Sharon Forsyth; Latha Kadalayil; Allan Hackshaw
Journal:  N Engl J Med       Date:  2012-05-03       Impact factor: 91.245

6.  Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

Authors:  Elif Hindié; Didier Mellière; Françoise Lange; Iyad Hallaj; Claire de Labriolle-Vaylet; Christian Jeanguillaume; Jacques Lange; Léon Perlemuter; Serge Askienazy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

7.  Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.

Authors:  H R Maxon; S R Thomas; V S Hertzberg; J G Kereiakes; I W Chen; M I Sperling; E L Saenger
Journal:  N Engl J Med       Date:  1983-10-20       Impact factor: 91.245

8.  An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.

Authors:  W H Beierwaltes; R Rabbani; C Dmuchowski; R V Lloyd; P Eyre; S Mallette
Journal:  J Nucl Med       Date:  1984-12       Impact factor: 10.057

9.  Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

Authors:  R Elisei; M Schlumberger; A Driedger; C Reiners; R T Kloos; S I Sherman; B Haugen; C Corone; E Molinaro; L Grasso; S Leboulleux; I Rachinsky; M Luster; M Lassmann; N L Busaidy; R L Wahl; F Pacini; S Y Cho; J Magner; A Pinchera; P W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2009-10-22       Impact factor: 5.958

10.  Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.

Authors:  H Tala; R Robbins; J A Fagin; S M Larson; R M Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2011-05-11       Impact factor: 5.958
View more
  12 in total

1.  Prophylactic central lymph node dissection in differentiated thyroid cancer.

Authors:  Julie A Goddard; David L Steward
Journal:  Endocrine       Date:  2013-05-23       Impact factor: 3.633

2.  Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases.

Authors:  Giovanni Conzo; Daniela Pasquali; Giuseppe Bellastella; Katherine Esposito; Carlo Carella; Annamaria De Bellis; Giovanni Docimo; Michele Klain; Sergio Iorio; Salvatore Napolitano; Antonietta Palazzo; Alessandra Pizza; Antonio Agostino Sinisi; Emilia Zampella; Antonio Bellastella; Luigi Santini
Journal:  Endocrine       Date:  2013-01-19       Impact factor: 3.633

3.  Radioiodide induces apoptosis in human thyroid tissue in culture.

Authors:  Eleonora Russo; Anna Guerra; Vincenzo Marotta; Antongiulio Faggiano; Annamaria Colao; Silvana Del Vecchio; Massimo Tonacchera; Mario Vitale
Journal:  Endocrine       Date:  2013-03-31       Impact factor: 3.633

Review 4.  Diagnosis and treatment of patients with thyroid cancer.

Authors:  Quang T Nguyen; Eun Joo Lee; Melinda Gingman Huang; Young In Park; Aashish Khullar; Raymond A Plodkowski
Journal:  Am Health Drug Benefits       Date:  2015-02

5.  Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?

Authors:  Rosj Gallicchio; Sabrina Giacomobono; Daniela Capacchione; Anna Nardelli; Francesco Barbato; Antonio Nappi; Teresa Pellegrino; Giovanni Storto
Journal:  Endocrine       Date:  2013-03-28       Impact factor: 3.633

6.  Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?

Authors:  Hyun Joo Shin; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Kyung Hwa Han; Jin Young Kwak
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

7.  Total thyroidectomy and central lymph node dissection. Experience of a referral centre for endocrine surgery.

Authors:  M Monacelli; R Lucchini; A Polistena; R Triola; C Conti; S Avenia; M S Di Patrizi; I Barillaro; A Boccolini; A Sanguinetti; N Avenia
Journal:  G Chir       Date:  2014 May-Jun

8.  Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients.

Authors:  Hyukjin Yoon; Sung Hoon Kim; Joo Hyun O; Ye Young Seo; Yeongjoo Lee; Hyoungwoo Kim; Jiyoung Ryu
Journal:  Nucl Med Mol Imaging       Date:  2015-09-01

9.  Hyperplastic thymus with increased angiogenesis is correlated with elevated serum thyroglobulin level in differentiated thyroid cancer patients with TENIS syndrome.

Authors:  Guangjian Zhang; Rui Gao; Yuanbo Wang; Yan Liu; Juan Li; Xi Jia; Yiqian Liang; Aimin Yang
Journal:  Oncotarget       Date:  2017-12-15

Review 10.  Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.

Authors:  Salvatore Micali; Stefania Bulotta; Cinzia Puppin; Angelo Territo; Michele Navarra; Giampaolo Bianchi; Giuseppe Damante; Sebastiano Filetti; Diego Russo
Journal:  BMC Cancer       Date:  2014-04-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.